Recall · openFDA Food Enforcement

Blue Razz 20mg Gummies Brand Name: None - unlabeled bulk…: FDA Recall H-0623-2025

Agency action: Aug 26, 2025Record ID: H-0623-2025
View official source ↗

What happened

Original notice title

Blue Razz 20mg Gummies Brand Name: None - unlabeled bulk (private-label consignee) Generic Name: Dietary Supplement Strength: 20mg CBD and 20mg D9 THC per gummy Dosage: Not declared at…

From the archived source record

Potential peanut protein cross-contact.

What the official notice says to do

Check the original notice for the instructions that apply to the named product, company, and affected lots.

Read the official notice →

Status and source details

Status recorded in the archive
Terminated
FDA recall classification
Class II
Recall initiated by
Voluntary: Firm initiated
Report date
Oct 1, 2025
Termination date in the archive
Oct 30, 2025
Source checked
Jul 16, 2026
Record revision
3442914c928f

This is a dated record. Its current status may have changed since the source was captured. A record applies to its stated scope; it is not a safety rating for every product from a company.

Sources, dates, and coverage →

What is affected

Product
Blue Razz 20mg Gummies Brand Name: None - unlabeled bulk (private-label consignee) Generic Name: Dietary Supplement Strength: 20mg CBD and 20mg D9 THC per gummy Dosage: Not declared at bulk stage (consignee determines serving size) Form: Gummy Administration: Oral Intended use: Dietary supplement for further packaging/labeling by consignee Type of packaging: Shipped in poly gusset bags, inside corrugated brown boxes, no consumer label applied. Net wt. Blue Razz: 24 bags x 5kg and 1 bag x 4kg UPC: N/A (unlabeled bulk) Firm name & address: None (no consumer label)
Company
Extract Labs, Inc.
Lot / identifier
Lot: 25JD082307A EXP: 07/2027 Printed on bulk bag identifier adhesive
Market / distribution
Product distributed throughout the United States and Australia, Germany, United Kingdom, Malaysia, and New/Zealand.